ストックスクリーナーアプリを入手
1.11
0.88%
0.02
前日終値:
$1.13
開ける：
$1.13
24時間の取引高:
26,622
Relative Volume:
0.59
時価総額：
$12.85M
収益：
$996.00K
当期純損益:
$-6.09M
株価収益率:
-2.0943
EPS:
-0.53
ネットキャッシュフロー:
$-9.76M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-1.72%
6か月 パフォーマンス:
+5.56%
1年 パフォーマンス:
-34.86%
1日の値動き範囲:
$1.10
$1.146
1週間の範囲:
$1.10
$1.23
52週間の値動き範囲:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
名前
Therapeuticsmd Inc
セクター
電話
561-961-1900
住所
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.11 | 13.43M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
146.53 | 67.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.68 | 45.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.455 | 44.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.61 | 18.97B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.44 | 13.28B | 2.41B | 305.80M | 492.20M | 2.95 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-08-07 | ダウングレード | Jefferies | Hold → Underperform |
| 2020-05-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 開始されました | Guggenheim | Buy |
| 2019-10-17 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-30 | 再開されました | Noble Capital Markets | Outperform |
| 2018-06-15 | 開始されました | JP Morgan | Overweight |
| 2017-09-08 | 開始されました | Morgan Stanley | Equal-Weight |
| 2017-07-11 | アップグレード | Oppenheimer | Perform → Outperform |
| 2017-05-09 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 再開されました | Jefferies | Buy |
| 2016-11-22 | 開始されました | Oppenheimer | Outperform |
| 2016-11-07 | 再開されました | Guggenheim | Buy |
| 2016-04-04 | 開始されました | Goldman | Buy |
| 2015-12-08 | 繰り返されました | Jefferies | Buy |
| 2015-12-08 | 繰り返されました | Stifel | Buy |
| 2015-09-21 | 繰り返されました | Jefferies | Buy |
| 2015-06-09 | 開始されました | Guggenheim | Buy |
| 2014-07-08 | 開始されました | FBR Capital | Outperform |
| 2014-04-17 | 繰り返されました | Noble Financial | Buy |
| 2014-01-28 | 繰り返されました | Noble Financial | Buy |
すべてを表示
Therapeuticsmd Inc (TXMD) 最新ニュース
What is the risk reward ratio of investing in TherapeuticsMD Inc. stockDaily Trading Strategy For Smart Trading - jammulinksnews.com
What are analysts’ price targets for TherapeuticsMD Inc. in the next 12 monthsDaily Trading Opportunities For Consistent Profits - jammulinksnews.com
What recovery options are there for TherapeuticsMD Inc.In-Depth Stock Trading Volume Analysis - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningFree Pattern Alert With ROI Driven Strategy - Newser
TherapeuticsMD Inc. stock trend forecastLow Capital High Return Stock Plans Reviewed - metal.it
Analyzing TherapeuticsMD Inc. with risk reward ratio chartsAlpha Trade Flow With Risk Calibration - Newser
Using data tools to time your TherapeuticsMD Inc. exitCapital Safe Picks with Consistent Gains - Newser
Will TherapeuticsMD Inc. see short term momentumWeekly Trend Screener with Momentum Picks - Newser
Quant Tools Rank TherapeuticsMD Inc. as High Risk High RewardEntry Alert Based on Volume Spikes Detected - metal.it
Candlestick Signal Suggests Reversal in TherapeuticsMD Inc.Triple Digit Growth Focused Trade Plan Reviewed - metal.it
Why TherapeuticsMD Inc. stock attracts strong analyst attentionPre-Market Stock Movement Summary and Review - Newser
What makes TherapeuticsMD Inc. stock price move sharplyMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Published on: 2025-07-30 00:06:51 - metal.it
Using flow based indicators on TherapeuticsMD Inc.Real-Time Analysis With Entry Targets In Progress - metal.it
TherapeuticsMD Inc. Stock Flags Risk Zone in Volatility IndexStep-by-Step Trade Signal Implementation Guide Ready - metal.it
Custom watchlist performance reports with TherapeuticsMD Inc.Momentum Detection with Entry Optimization - Newser
Visual trend scoring systems applied to TherapeuticsMD Inc.Free Conservative Long Term Growth Plans - Newser
How TherapeuticsMD Inc. stock performs during market volatilityMomentum Screener with Buy and Sell Areas - Newser
What to expect from TherapeuticsMD Inc. in the next 30 daysFree ROI Boosting Trade Opportunity Calendar - Newser
TherapeuticsMD Inc. Crosses 200 Day MA — Signal or NoiseFast Exit and Entry Strategy Guide Offered - metal.it
TherapeuticsMD Inc. Flashes Buy Signal on Multi Timeframe ChartEntry Alert With Low Drawdown Strategy Noted - metal.it
When is TherapeuticsMD Inc. stock expected to show significant growthInvest confidently with actionable market data - jammulinksnews.com
How to interpret RSI for TherapeuticsMD Inc. stockReliable Setup Screener with Low Risk - Newser
Should I hold or sell TherapeuticsMD Inc. stock in 2025Expert guidance for superior capital growth - jammulinksnews.com
Published on: 2025-07-28 06:06:00 - jammulinksnews.com
What are the latest earnings results for TherapeuticsMD Inc.Access high-yield investment alerts now - jammulinksnews.com
Is TherapeuticsMD Inc. a growth stock or a value stockUnlock real-time stock alerts for quick profits - jammulinksnews.com
Is TherapeuticsMD Inc. a good long term investmentHigh-yield capital appreciation - PrintWeekIndia
What analysts say about TherapeuticsMD Inc. stockFree Stock Movement Tracking - Autocar Professional
What drives TherapeuticsMD Inc. stock priceRecord-breaking gains - PrintWeekIndia
Is TherapeuticsMD Inc. stock overhyped or has real potentialTremendous return on equity - jammulinksnews.com
TherapeuticsMD Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - Autocar Professional
Therapeuticsmd Inc (TXMD) 財務データ
収益
当期純利益
現金流量
EPS
Therapeuticsmd Inc (TXMD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
| Collins Cooper C. | Director |
Aug 22 '24 |
Buy |
1.73 |
4,094 |
7,099 |
52,016 |
| Collins Cooper C. | Director |
Aug 21 '24 |
Buy |
1.70 |
1,200 |
2,039 |
47,922 |
0.46%
1.21%
大文字化:
|
ボリューム (24 時間):